Keeping Pace with Bronchiectasis: Early Diagnosis, Management, and Emerging Treatments

Supported by an educational grant from Insmed.

Program Description

Non-cystic fibrosis bronchiectasis (NCFBE) is a progressive pulmonary condition that leads to bronchial wall damage causing permanent airway dilation, which is primarily due to neutrophil-driven inflammation stemming from chronic or recurrent infection. In patients with bronchiectasis, symptoms such as persistent cough, dyspnea, excessive sputum production, and recurrent pulmonary infections can worsen the disease and lead to impaired quality of life.

This CME satellite symposium, presented by National Jewish Health, will focus on assessment of NCFBE, including the disease burden, unmet needs, associated patient risk factors, comorbidities, and approaches to reduce delay in diagnosis. Attendees will become more adept at assessing patients’ natural history, clinical course, and disease progression. They will deepen their understanding of the role of neutrophilic inflammation and neutrophil serine protease inflammation (NSP) in NCFBE and learn about current and emerging treatments to improve patient outcomes in NCFBE.

At the completion of the activity, attendees will be able to:

1. Review bronchiectasis burden, etiologies, and risk factors.
2. Apply best practices for early diagnosis of bronchiectasis.
3. Identify the role of neutrophilic inflammation in patients with bronchiectasis.
4. Select best options for management of bronchiectasis.

Accreditation and Designation Statements:

National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

National Jewish Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This symposium is not supported, endorsed, or accredited by the American College of Chest Physicians.

Speakers

Pamela J. McShane, MD
University of Texas Health Science Center
Division of Pulmonology & Critical Care
Professor of Medicine
Tyler, TX

Charles L. Daley, MD
National Jewish Health
Division of Mycobacterial and Respiratory Infections
Chief
National Jewish Health, University of Colorado School of Medicine, and Icahn School of Medicine at Mt. Sinai
Professor of Medicine
Denver, CO

Steven E. Lommatzsch, MD
National Jewish Health
Pulmonary and Critical Care Division
Associate Professor of Medicine
National Jewish Health
Non-CF Bronchiectasis Program
Director
National Jewish Health
PCD Clinic
Co-Director
Denver, CO